<DOC>
	<DOCNO>NCT00531687</DOCNO>
	<brief_summary>Study Objectives : Primary objective - The primary objective study investigate combination cisplatin/gemcitabine/paclitaxel , respect complete remission patient germ cell tumour previously treat BEP . Secondary Objectives - Overall survival - Progression free survival - Response rate ( RECIST ) - Duration response - To investigate safety paclitaxel , gemcitabine cisplatin patient previously treat BEP</brief_summary>
	<brief_title>Trial Paclitaxel , Gemcitabine Cisplatin Patients With Relapsing Germ Cell Cancer</brief_title>
	<detailed_description>relevant</detailed_description>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically confirm germ cell tumor ( seminoma nonseminoma ) measurable metastatic disease either radiography ( site previously irradiate ) elevation alpha fetoprotein ( AFP ) and/or elevation betahuman chorionic gonadotropin ( betaHCG ) ; Patient previously treat standard BEP ( 3 4 cycle ) relapse 1 month favorable response previous chemotherapy ( CR PR ) Male Age great equal 18 year ; Performance status 0,1,2 3 WBC &gt; 3000 mill/l , ANC &gt; 1500 mill/l , platelet count &gt; 100.000 mill/l ; serum bilirubin &lt; 1.5 x upper limit normal ; Adequate renal function ( Glomerular Filtration Rate ( GFR ) &gt; 60 ml/min ) . GFR assess direct measurement ( EDTA clearance creatinine clearance ) sign informed consent ; Uncontrolled active severe clinical infection ( CTC grade 3 4 ) . Serious concomitant systemic disorder incompatible study ( discretion investigator ) , include expect difficulty followup relate mental disorder . Grade 2 great peripheral neuropathy accord CTC , version 3.0 . Second malignancy basal squamous cell skin cancer .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>relapse</keyword>
</DOC>